Acute myeloid leukemia (AML) is a biologically complex and molecularly and clinically
heterogeneous disease, and its incidence is increasing as the population ages …

Acute myeloid leukemia (AML) is the most frequently diagnosed acute leukemia, and its
incidence increases with age. Although the etiology of AML remains unknown, exposure to …

Abstract Purpose of Review The field of acute myeloid leukemia (AML) has been
revolutionized in recent years by the advent of high-throughput techniques, such as next …

Although standard therapy for AML has been relatively constant over the past 2 decades,
this may be changing with enhanced technologies allowing for the classification of acute …

Acute myeloid leukemia (AML) is a disease with marked heterogeneity in both response to
therapy and survival. Cytogenetics, age, and performance status have long determined …

Abstract Purpose of Review Awareness of the molecular landscape of AML has improved
AML care over the last 5 years. This review summarizes updates regarding the diagnostic …

Research into the underlying pathogenic mechanisms of acute myeloid leukemia (AML) has
led to remarkable advances in our understanding of the disease. Mutations now allow us to …

Molecular characterization of acute myeloid leukemia and its... : Current Opinion in Oncology
Molecular characterization of acute myeloid leukemia and its impact on treatment : Current …

Acute myelogenous leukemia (AML), although an uncommon disorder, is a useful prototype
for the treatment of malignancies in general. Significant advances have been made in both …

Acute myeloid leukemia (AML) is a malignancy of the stem cell precursors of the myeloid
lineage (red blood cells, platelets, and white blood cells other than B and T cells). Like other …